Skip to main content
PLOS Biology logoLink to PLOS Biology
. 2021 Sep 9;19(9):e3000923. doi: 10.1371/journal.pbio.3000923

Assessment of single-vessel cerebral blood velocity by phase contrast fMRI

Xuming Chen 1,2,#, Yuanyuan Jiang 3,#, Sangcheon Choi 1,4, Rolf Pohmann 1, Klaus Scheffler 1,5, David Kleinfeld 6,7, Xin Yu 3,*
Editor: Aniruddha Das8
PMCID: PMC8454982  PMID: 34499636

Abstract

Current approaches to high-field functional MRI (fMRI) provide 2 means to map hemodynamics at the level of single vessels in the brain. One is through changes in deoxyhemoglobin in venules, i.e., blood oxygenation level–dependent (BOLD) fMRI, while the second is through changes in arteriole diameter, i.e., cerebral blood volume (CBV) fMRI. Here, we introduce cerebral blood flow–related velocity-based fMRI, denoted CBFv-fMRI, which uses high-resolution phase contrast (PC) MRI to form velocity measurements of flow. We use CBFv-fMRI in measure changes in blood velocity in single penetrating microvessels across rat parietal cortex. In contrast to the venule-dominated BOLD and arteriole-dominated CBV fMRI signals, CBFv-fMRI is comparable from both arterioles and venules. A single fMRI platform is used to map changes in blood pO2 (BOLD), volume (CBV), and velocity (CBFv). This combined high-resolution single-vessel fMRI mapping scheme enables vessel-specific hemodynamic mapping in animal models of normal and diseased states and further has translational potential to map vascular dementia in diseased or injured human brains with ultra–high-field fMRI.


This study presents a phase contrast-based, high field MRI-based approach for the functional mapping of cerebral blood velocity in individual cortical arterioles and venules in the rat cortex; this approach can be combined with previously established approaches to map BOLD, CBV, and blood velocity from penetrating microvessels.

Introduction

Cerebral blood flow (CBF) is a key hemodynamic readout coupled to neuronal dynamics and viability in normal and diseased brain states [1]. Changes in CBF may be monitored directly within individual blood vessels through the use of optical-based particle tracking techniques [2]. A variety of imaging methods have been developed to measure CBF across multiple spatial scales, from capillary beds up through brain-wide vascular networks in animal brains. These include in vivo multiphoton microscopy [3], optical coherence tomography [4], optoacoustic imaging [5], and laser doppler and speckle imaging [6,7]. In particular, doppler based functional ultrasound imaging provides a unique advantage to detect the CBF in the brain with a high spatiotemporal resolution, which can be readily applied for awake animal imaging [810]. However, the spectrum-specific signal transmission in ultrasound methods cannot effectively pass the skull of animals without significant degradation of the signal-to-noise ratio (SNR). Typically, a craniotomy or a procedure to thin the skull is needed to detect the hemodynamic signal [2]. While current techniques support transcranial imaging into the superficial layers of the cortex [1113], only functional MRI (fMRI) provides a noninvasive approach for measuring hemodynamic signals throughout the brain.

Changes in CBF may be detected by fMRI that is based on arterial spin labeling (ASL), in which water protons in a major upstream vessel are spin-polarized with an additional radio frequency (RF) B1 field [1416]. The ASL-based CBF fMRI technique detects local changes in the flow of blood through brain tissue [17]. Two other fMRI-based techniques provide indirect information about changes in CBF. Blood oxygenation level–dependent (BOLD) fMRI is used to determine changes in the ratio of deoxy to oxyhemoglobin in the blood and is an indirect measure of changes in brain metabolism [14,18,19]. Cerebral blood volume (CBV) fMRI is used to measure changes in blood volume, i.e., essentially changes the diameter of arterioles, based on the use of exogenous contrast agents, e.g. monocrystalline iron oxide nanoparticle (MION), or the endogenous vascular-space-occupancy (VASO) mapping scheme to differentiate blood from brain tissue [2023].

In contrast to the ASL-based orientation-specific flow measurement [2427], phase contrast (PC) MRI relies on gradient-oriented dephasing of magnetized protons to map the velocity, i.e., direction and speed, of blood flow [28,29]. Past work with 7 T MRI showed that PC-MRI can be used to measure flow in the perforating arteries through the white matter and the lenticulostriate arteries in the basal ganglia of human brains [3033]. However, the SNR was insufficient in these prior studies to map changes in flow, and thus changes in CBF, concurrent with changes in neuronal activation.

Here, we report on a PC-MRI method to detect vessel-specific changes in blood velocity on the timescale of single trials. We denote this method cerebral blood flow–related velocity, abbreviated CBFv. We build on past implementations of PC-MRI [30,3437]. Here, we utilize a small surface RF coil with high-field MRI, i.e., 14.1 T, for improved SNR. This advance allows us to map the BOLD, CBV, and CBFv-fMRI signals from individual penetrating venules and arterioles, which span 20 to 70 μm diameter, with high spatial resolution [22,38,39].

Results

Phantom validation of high-resolution PC-based flow velocity measurement

For calibration, we constructed an in vitro capillary tubing circulatory system to mimic penetrating vessels, with flow rates from 1 to 10 mm/s (Fig 1A). A 2D PC-MRI slice is aligned perpendicular to the capillary tubing (Fig 1A and 1B) and provides a voxel-specific measurement of the flow velocity through 2 tubes with the upward flow (positive sign, bright dots in Fig 1B) and 2 tubes with the downward flow (negative sign, dark dots in Fig 1B), as well as a control tube. We observe a monotonic and near linear relation between the velocity measured by PC-MRI and the true velocity: Vmeas = (0.67 ± 0.01) Vpump + (0.02 ± 0.11) mm/s at echo time (TE) = 5.0 ms (Fig 1C). The small offset could be caused by eddy current effects and other gradient-related scaling errors of the PC-MRI sequence [4042]. We further observe that the measured velocities are relatively insensitive to the value of TE (Fig 1C).

Fig 1. In vitro flow velocity measurements with PC-MRI.

Fig 1

(A) Schematic drawing of the phantom experimental flow chamber in the 14.1 T scanner. An expanded image (red box) shows the circulatory system constructed of capillary tubes. A representative FLASH MRI image (blue box), 500 μm in thickness, shows the capillary positions. ROIs T1 and T2, contoured in purple, indicate the upward flow. ROIs T3 and T4, in orange contour, indicate the downward flow. The green contour indicates the stagnant fluid. (B) Representative images with different flow velocity in the capillaries T1 to T4 in panel A. TE = 5.0 ms for all panels. (C) The plot of flow velocity estimates from the 5 ROIs with different TEs, as marked, and different pump rates, as indicated and marked in panel B. The dotted lines correspond to a linear fitting for velocity measurements of different ROIs. The data underlying this figure can be found in S1 Data. FLASH, fast low angle shot; PC, phase contrast; ROI, region of interest; TE, echo time.

We implemented the high-resolution PC-MRI with 14.1 T MR scanning for in vivo measurement of blood flow from individual penetrating arterioles and venules. We collected data throughout the infragranular cortex, i.e., layer V, of anesthetized rats. A surface RF transceiver coil with 6-mm diameter was constructed and attached to the rat skull (S1 Fig) to improve the SNR of PC-MRI images as well as multi-gradient echo (MGE) images used for arteriole–venule (A–V) mapping [22,38]. This coil was essential for the high-resolution mapping with a fast sampling rate of the single-vessel flow velocity over a complete hemisphere of the rat brain (Figs 2A and S1E).

Fig 2. PC-based single-vessel flow velocity (CBFv) mapping.

Fig 2

(A) Representative 2D MGE slices (yellow boxes) from a deep layer of the primary forepaw somatosensory cortex (first frame) at different TEs, as indicated. (B) The 2D A–V map (yellow box) derived from the images with different TEs in panel A, arterioles, and venules appear as bright and dark voxels, respectively. The expanded views (red boxes) show individual venules, i.e., black voxels marked in blue, and arterioles, i.e., white voxels marked in red. (C) The vectorized flow velocity map (blue box) from the same 2D MGE slice in panel B. The expanded views (green boxes) show the individual venules, i.e., white dots with positive velocity, and arterioles, i.e., black dots with negative velocity. Note that 2 bright dots are caused by the “overflowed” velocity beyond the maximal velocity, i.e., the Venc parameter, defined in the PC-MRI sequence, which could be not correctly estimated. (D) Scatter plot of the flow velocities from individual arterioles and venules as the function of the normalized signal intensities of each vessel in the A–V map of panel B, data from 11 rats as indicated. Insert shows the blood flow direction of arterioles and venules in the forepaw somatosensory cortical region. The lower panel shows the histogram of the blood velocity distribution across arterioles and venules, as well as the bar graph to show the mean velocity. The data underlying this figure can be found in S2 Data. A–V, arteriole–venule; CBFv, cerebral blood flow–related velocity; MGE, multi-gradient echo; PC, phase contrast; ROI, region of interest; Venc, velocity encoding; TE, echo time.

In vivo PC-based flow velocity mapping of penetrating microvessels

We first acquired the single-vessel A–V map by aligning a 500-μm thick 2D MRI slice perpendicular to penetrating vessels through layer V of one hemisphere (Fig 2A and 2B). We designed the pulse sequence for PC-MRI to achieve the same slice geometry of the A–V map so that the CBF deduced from PC-MRI signals could be overlaid with individual penetrating arterioles and venules in the single-vessel flow velocity map (Fig 2A and 2C). The arteriole blood flows into the cortex, while the venule blood flows outward, which determines the sign of the flow velocity. Vessel-specific velocities were plotted as a function of the normalized signal intensity in the A–V map and corroborated our ability to determine flow velocity specific to arterioles and venules (Fig 2C and 2D). The measured flow velocities range from 1 to 10 mm/s, as previously measured with optical methods [43,44]. To probe the reliability of the single-vessel MR-based flow velocity method, we compared the velocities detected by PC-MRI methods with different TEs and flip angles and observed comparable results across a range of parameters (S2 Fig). It should be noted that altered vessel velocities detected from the same animal depend on the vessel sizes and orientation angles relative to the 2D slice. Lastly, the large variability of blood velocity across different animals could be caused by the varied physiological states of animals under anesthesia, as well as by degraded gradient performance during high duty cycle PC-MRI; see optimization step in Methods. All told, these data demonstrate the feasibility of in vivo PC-based blood velocity mapping from individual penetrating arteriole and venules.

PC-based CBFv-fMRI from individual arterioles and venules

We contrasted the complementary capabilities of PC-based CBFv-fMRI against the signals observed with the balanced steady-state free precession (bSSFP)-based single-vessel BOLD- and CBV-fMRI mapping method [38] (Fig 3). We first created an A–V map through the infragranular layers of the forepaw region of the primary somatosensory cortex (Fig 3Ai), followed by 2D-bSSFP to detect stimulus-induced changes in the single-vessel BOLD fMRI signal (Fig 3Aii). We next performed single-vessel PC-MRI flow velocity measurements to measure baseline flow in penetrating arterioles and venules, using 100 × 100 μm2 in-plane resolution, a sampling rate of 4-second repetition time (TR) per image and the same geometry as the 2D-bSSFP method (Fig 3Aiii). Changes in CBFv upon stimulation overlapped with individual penetrating vessels in the A–V map (Fig 3Aiv). Lastly, we performed 2D-bSSFP for single-vessel CBV-fMRI mapping by intravenous injection of iron particles into the blood in the same animals (Fig 3Av). The BOLD fMRI signal is primarily detected from individual penetrating venules, while the CBV-weighted signal is mainly located at the individual penetrating arterioles (dark dots in Fig 3Aii with bright dots in Fig 3Av). In contrast, the CBFv-fMRI signal is observed in both the penetrating arterioles and venules (Fig 3Aiv).

Fig 3. Maps of task-related hemodynamic signals with single-vessel BOLD, CBV, and CBFv-fMRI.

Fig 3

(A) Different MRI measurement strategies on the same 2D slice. From left to right: (i) the A–V map defines arterioles as bright dots and venules as dark dots; (ii) the evoked bSSFP-based BOLD fMRI map, within a green subregion, on top of the A–V map; (iii) the PC-MRI map of baseline CBFv; (iv) the CBFv-fMRI map on top of the A–V map with an increased flow velocity corresponding to brighter voxels for venules and darker voxels for arterioles; and (v) evoked bSSFP-based CBV-fMRI map on top of the A–V map. (B) The time courses of evoked bSSFP-BOLD and CBV-fMRI with the block design paradigm from venules and arterioles shown in panel A. Forepaw stimulation pulse of 330 μs in width and 1 mA in amplitude delivered at 3 Hz for 10 seconds. (C) Averaged time courses of the fractional change for evoked BOLD and CBV signals from venule and arteriole ROIs of different rats (mean ± SEM, the green bar shows stimulation duration). (D) The time courses of the evoked CBFv changes from the arteriole and venule ROIs show increased velocity from both arterioles and venules with the block design, 10-second duration stimulation paradigm. (E) The averaged time courses of the evoked CBFv changes show the velocity increase from both arteriole and venule ROIs with the block design stimulation paradigm from 5 rats (mean ± SEM, the green bar shows stimulation duration). (F) Bar graph shows that peak BOLD changes of venule are significantly higher than those of arteriole (5 rats, p = 0.009), while the peak CBV changes of arteriole are significantly higher than those of venule (3 rats, p = 0.028). In contrast, the peak CBFv changes are only slightly, but not significantly, higher in venules than arterioles (5 rats, p = 0.063). The data underlying this figure can be found in S3 Data. A–V, arteriole–venule; BOLD, blood oxygenation level–dependent; bSSFP, balanced steady-state free precession; CBFv, cerebral blood flow–related velocity; CBV, cerebral blood volume; ROI, region of interest.

The stimulus-evoked responses of all CBV, BOLD, and CBFv-fMRI signals were studied with an on/off block design (Fig 3B–3E). Group analysis shows that the positive BOLD signal from venule voxels is significantly higher than the arteriole-specific BOLD signal (Fig 3C). In contrast, the arteriole dilation leads to an earlier CBV-weighted negative fMRI signal, which is much stronger and faster than the signal from passive venule dilation (Fig 3C), as expected [4547]. Group analysis shows the similar temporal dynamics of CBFv changes, but with different signs in arterioles and venules (Fig 3D). In contrast to the venule-dominated BOLD and arteriole-dominated CBV responses (Fig 3C and 3F), the percentage changes in CBFv-fMRI is statistically indistinguishable between arterioles (3.12 ± 0.87%) and venules (3.60 ± 0.80%) (Fig 3E and 3F). The voxel-wise hemodynamic changes of BOLD, CBV, and CBFv are illustrated in S3 Fig and S1 Movie.

Discussion

Despite the plethera of existing tools developed for CBF measurements in both animal and human brains, it remains challenging to noninvasively detect the flow dynamics of intracortical microvessels. Here, we optimized PC-MRI to map the vectorized single-vessel flow velocity of penetrating arterioles and venules and further developed the single-vessel CBFv-fMRI technique to directly measure flow velocity in rat brains. In combination with previously established single-vessel BOLD- and CBV-fMRI methods, the PC-based single-vessel CBFv-fMRI method provides complementary information to map vessel-specific hemodynamic responses with high-resolution fMRI.

In contrast to the conventional ASL methods, PC-based MRI mapping allows arterioles and venules to be distinguished for simultaneous velocity measurements through a 2D plane. Also, ASL has less vascular specificity because water exchange through the blood–brain barrier of capillary beds increases the weighting of the ASL-based flow signal for parenchyma voxels [48,49]. Furthermore, there is significant variability in the transit time to flow from arterioles to venules through the capillary bed [50], which complicates the distinction of arterioles and venules by simple ASL-based CBF mapping. We detected the velocity from penetrating microvessels in the deep cortical layers with PC-MRI, with velocity values from 1 to 10 mm/s (Fig 2). It is noteworthy that the PC-based vessel velocity measurement is based on measuring water protons in blood but not limited to the flow of red blood cells. Still, the PC-based velocity from microvessels matches well with the previous optical measurement [2,43,44]. We conclude that high-resolution PC-MRI is ideal for noninvasive single-vessel CBFv-fMRI mapping.

The noninvasive measurement of microvessel blood velocity changes coupled to neuronal activation is a critical step to elucidate the neurovascular coupling mechanism underlying a variety of brain disorders in animal models. Existing methods, e.g., multiphoton microscopy [3,51,52] or doppler based ultrasound imaging [810], enable the detection of red blood cell velocity or CBF/CBV from microvessels with ultra-high resolution. Yet ultrasound requires a craniotomy or thinned skull [53] for effective spectrum-specific signal transmission through deep cortical layers or subcortical regions in rats and other animals. Such a surgical procedure has been well documented to induce perturbation of the physiological microenvironment in the brain [5456], which potentially confounds the disease-related functional CBF measurements in animal brains. In contrast, conventional MRI methods, including PC-MRI, mainly detect blood flow or velocity in large vessels and seldom identify the functional CBFv of penetrating microvessels in the brain. By implementing a local RF coil with the high-field MR scanner, our work showed the feasibility to map the velocity changes from individual penetrating arterioles and venules with diameter 20 to 70 μm [22,38].

The novel applications of PC-based CBFv-fMRI can be divided into 2 different directions. First, the PC-based CBFv-fMRI provides a possible scheme to be combined with single-vessel BOLD and CBV fMRI signals for quantitative assessment of the cerebral metabolic rate of oxygen utilization in relation to flow [57]. These vessel-specific hemodynamic measurements can then be used to potentially validate the calibrated BOLD model [58] in future studies. Secondly, we now have a means to test the resting-state single-vessel correlation patterns of CBFv signals from penetrating arterioles and venules (S4 Fig). In contrast to the T2*-weighted resting-state readout of BOLD or CBV signal fluctuation [38], which amplifies the contrast-to-noise ratio (CNR) from the vessel-specific oxygenation or vessel diameter changes, CBFv signal fluctuation from penetrating microvessels provides a direct measurement of blood velocity changes across a large field of view. The measurement of PC-based CBFv signal fluctuation from microvessels can be further combined with single-vessel CBV-fMRI to study the vascular dynamic mechanism that underlies vasomotion-mediated perivascular clearance in animal models with Alzheimer disease (AD) [59,60]. In particular, both vasomotion-based ateriole diameter changes, i.e., the CBV signal fluctuation, and corresponding blood velocity changes, i.e., CBFv signal fluctuation, can be mapped across hippocampal penetrating vessels. This may be further combined with simultaneous fiber photometry based fluorescent recordings from genetically encoded biosensors [39] to identify the pathological vasodynamics in transgenic AD animals.

The accurate measurement of PC-based CBFv from microvessels relies on multiple factors. First, a remaining complication with PC-MRI mapping is the presence of small offsets in velocity as shown in our phantom capillary tubing studies with circulating flow under different conditions. The phase-dependent velocity encoding depends on the quality of the magnetic field gradients, and mismatched eddy currents of multiple gradients with opposite polarities, as well as the nonlinear and distorted gradient fields, could contribute to distortions in gradients [4042]. We have described a list of parameters that should be optimized when implementing high-resolution PC-based CBFv measurements (Methods). Also, the high-resolution PC-MRI method is a high duty cycle sequence and slight heating of the gradient coil during scanning may alter the gradient performance, consistent with the baseline drift of the CBFv-fMRI signal in the first 5 minutes of scanning (Fig 3D). Nevertheless, it should be noted that the percentage velocity changes from individual arterioles and venules can be readily detected with the PC-based CBFv-fMRI measurement regardless of the gradient heating–related baseline drift. Another factor that contributes to the phase-dependent velocity error originates from the limited spatial resolution of PC-MRI images in comparison to the diameters of small vessels, i.e., the partial volume effect [36], although corrections are possible [30,37].

The present work shows the feasibility of PC-based CBFv-fMRI in rat brains using a ultra–high-field strength MR scanner (14 T). It should be noted that the high-resolution PC-based CBFv measurement can also be applied with a 9.4 T scanner to detect the microvessel blood velocity at a similar scale to 14 T measurement (S5 Fig). This supports a broader usage of noninvasive animal CBFv mapping. The translational potential of the PC-based CBFv-fMRI remains to be investigated. Previously, we detected low-frequency fluctuation of single-vessel resting state BOLD fMRI signals (TR = 1 second) from individual sulcus veins and arteries in the occipital lobe of the human brain [38]. The T2*-weighted BOLD resting state fMRI signal fluctuation from individual vessels can be separated from noise artifacts due to pulsation or other motion effects. In contrast, pulsation could be a significant confounding issue for PC-based blood velocity mapping from individual vessels [61,62]. To better differentiate the pulsational contribution to CBFv signal fluctuation given different frequency ranges, we will need to increase the sampling rate by implementing phased-array surface coils for focal field of view measurement and an accelerated PC-MRI sequence.

Methods

Design of a phantom capillary tubing flow system

To validate the PC-MRI sequence, a plastic circulatory flow phantom composed of the capillary tubing (PE-10, Instech Laboratories, (Plymouth Meeting, PA, USA) inner diameter 210 μm) was constructed to mimic the geometry of cortical blood vessels (Fig 1A). The capillary tube was connected to a programmable syringe infusion/withdraw pump (Pump Elite 11, Harvard Apparatus, Holliston, MA, USA) with an infusion rate of 0.25, 0.5, 1.0, 1.5, and 2.0 mL/h, which were transferred to the flow velocity of the capillary tubing as shown in Fig 1. We infused manganese solution (50 mM MnCl2, Sigma-Aldrich, Germany) through the tubing. The phantom capillary tubing was immersed in Fomblin (Sigma-Aldrich, Germany) to avoid air interface artifacts.

Animal preparation for fMRI

All surgical and experimental procedures were approved by local authorities (Regierungspraesidium, Tübingen Referat 35, Veterinärwesen, Leiter Dr. Maas, protocol #KY 2/14 2/17) and were in full compliance with the guidelines of the European Community (EUVD 86/609/EEC) and guidelines of the Animal Care and Use Committee and the Animal Health and Care Section of Massachusetts General Hospital. The experimental animals were Sprague-Dawley male rats, approximately 250 g, provided by the Charles River Laboratories. A total of 25 rats were used in all experiments (the evoked bSSFP-BOLD/CBV and PC-MRI signals were acquired from 5 of 25 rats).

Detailed surgical procedures have been described previously [38,39]. Briefly, rats were first anesthetized with isoflurane, 5% (v/v) induction, and 1% to 2% (v/v) maintenance, and each rat was orally intubated with a mechanical ventilator (SAR-830, CWE, PA, USA). The femoral artery and vein were catheterized with plastic catheters (PE-50, Instech Laboratories) to monitor the arterial blood gas, administrate drugs, and constantly measure the blood pressure. After catheterization, rats were secured in a stereotaxic apparatus, and a custom-made RF coil was fixed above the skull with cyanoacrylate glue (454, Loctite, Henkel, Dusseldorf, Germany). After surgery, isoflurane was switched off and a bolus of α-chloralose (80 mg/kg, Sigma-Aldrich, Germany) was intravenously injected. A mixture of α-chloralose (26.5 mg/kg/h) and the muscle relaxant (pancuronium bromide, 2 mg/kg/h) was continuously infused to maintain the anesthesia and minimize motion artifacts. Throughout the whole experiment, the rectal temperature of rats was maintained at 37°C by using a feedback heating system. All relevant physiological parameters were constantly monitored during imaging, including heart rate, rectal temperature, arterial blood pressure, the pressure of the tidal ventilation, and end-tidal CO2. Arterial blood gases were checked to guide the physiological status adjustments by changing the respiratory volume or administering sodium bicarbonate (NaBic 8.4%, Braun, Melsungen, Germany) to maintain normal pH levels. Dextran-coated iron oxide particles (15 to 20 mg of Fe/kg, BioPAL, Massachusetts, USA) were intravenously injected for CBV-weighted signal acquisition.

fMRI setup

All images were acquired with a 14.1 T, 26 cm horizontal bore magnet (Magnex Scientific, Oxford, UK) interfaced through the Bruker Advance III console (Bruker, Billerica, Massachusetts, USA). The scanner is equipped with a 12-cm magnet gradient set capable of providing a strength of 100 G/cm and a 150 μs rise time (Resonance Research, Billerica, MA, USA). We also applied the 9.4 T scanner (Bruker) with a 21-cm bore size (Magnex Scientific) to test the PC-MRI sequence. A custom-made transceiver coil with an internal diameter of 6 mm was used for fMRI image acquisition. For the electrical stimulation, 2 custom-made needle electrodes were placed on the forepaw area of the rats to deliver the electrical pulse sequences; 330 μs duration at 1.0 ~ 2.0 mA repeated at 3 Hz for 10 seconds using a stimulus isolator (A365, WPI, Sarasota, FL, USA). The stimulation duration and frequency were triggered directly through the MRI scanner which was controlled by Master-9 A.M.P.I. system (Jerusalem, Israel). The triggering pulses from the MRI scanner were also recorded by the Biopac system (MP150, Biopac Systems, USA).

Single-vessel MGE imaging

To anatomically map individual arterioles and venules penetrating deep cortical layers of the somatosensory cortex, a 2D MGE sequence was applied with the following parameters: TR = 50 ms; TE = 2.5, 5.0, 7.5, 10.0, 12.5, and 15.0 ms; flip angle = 55°; matrix = 192 × 192; in-plane resolution = 50 × 50 μm2; slice thickness = 500 μm. The A–V map was made by averaging MGE images from the second echo to the fifth echo. In the A–V map, the arteriole voxels show bright (red marks) due to the in-flow effect and venule voxels show as dark dots (blue marks) because of the fast T2* decay (Fig 2B).

bSSFP BOLD- and CBV-fMRI

The bSSFP sequence was applied to acquire the evoked BOLD signals by using the following parameters: TR = 15.6 ms; TE = 7.8 ms; flip angle = 15°; matrix = 96 × 96; FOV = 9.6 × 9.6 mm2; in-plane resolution = 100 × 100 μm2; slice thickness = 500 μm. For the bSSFP CBV-fMRI, the parameters were adjusted with TR = 10.4 ms and TE = 5.2 ms. The total TR to acquire each image is 1 second. To reach the steady state, 300 dummy scans were used, followed by 25 pre-stimulation scans, 1 scan during stimulation, and 44 post-stimulation scans with 10 epochs for each trial. The fMRI stimuli block design of each trial consisted of 10-second stimulation and 35-second interstimulus interval. The total acquisition duration of each trial was 7 minutes 55 seconds. CBV-weighted fMRI signals were acquired after intravenous injection of dextran-coated iron oxide particles (15 ~ 20 mg of Fe/kg, BioPAL).

PC-MRI

To measure the flow velocity of individual arterioles and venules, the PC-MRI sequence was applied with the following parameters. For the in vitro phantom and in vivo single-vessel CBFv measurement: TR = 15.6 ms; TE = 4.2, 4.5, 5.0, 6.0 ms; flip angle = 25°; FOV = 6.4 × 6.4 mm2; matrix = 128 × 128; in-plane resolution = 50 × 50 μm2; slice thickness = 500 μm; maximum velocity encoding (Venc) = 0.66 to 1.56 cm/s (based on the flow values). The total acquisition time was 11 minutes 28 seconds. For the in vivo CBFv-fMRI measurements: TR = 15.6 ms; TE = 5 ms; flip angle = 30°; FOV = 6.4 × 6.4 mm2; matrix = 64 × 64; in-plane resolution = 100 × 100 μm2; slice thickness = 500 μm. A total TR for each image is 4 seconds. The total acquisition duration of each trial was 16 minutes. The total acquisition duration of each trial was 16 minutes. For in vivo single-vessel CBFv measurement with 9.4T scanner: TR = 15.6 ms; TE = 5.0 ms; flip angle = 15°; FOV = 6.4 × 6.4 mm2; matrix = 96 × 96; in-plane resolution = 67 × 67 μm2; slice thickness = 500 μm; maximum Venc = 0.91 to 1.58 cm/s (based on velocity values). To measure the blood flow velocity, bipolar flow encoding gradients were applied along the slice encoding direction. The slice position was anatomically identical with the slice position of the MGE imaging.

Parameter optimization for the single-vessel CBFv mapping

(i) The orientation of the 2D slice should be parallel to the x-z plane of the magnet when performing slice-oriented velocity measurement, which would reduce cross-axis gradient-dependent error. (ii) The Venc value needed to be matched with the maximal velocities likely to be encountered within the vessel of interest. Since the Venc value is inversely proportional to the bipolar gradient, the minimal Venc value depends on the gradient strength. It should be noted that too low Venc values could also lead to gradient heating artifacts due to the high duty cycle. (iii) We usually applied high-order MapShim to improve the field homogeneity before the high-resolution PC-MRI. Meanwhile, to remove field homogeneity-related phase offset, a pair of toggled bipolar gradients was typically applied. It is important to note that the mismatched amplitudes of toggled bipolar gradient amplitudes or related eddy currents could lead to background velocity error. We could manually calibrate the appropriate gradient amplitude using the build-in parameters of the Bruker system, i.e., PVM_PPGradAmpArray.

Data analysis and statistics

All data preprocessing and analysis were performed by using the software package, Analysis of Functional NeuroImages (AFNI) (NIH, Bethesda, USA). All relevant fMRI analysis source codes can be downloaded from (https://afni.nimh.nih.gov/pub/dist/doc/htmldoc/background_install/main_toc.html).

Definition of the individual vessels

The individual arteriole/venule voxels were defined by the signal intensity of the A–V map [22]. The arterioles are determined if the voxel intensities are higher than the mean signal intensities plus 2 times the standard deviation of the local area in a 5 × 5 kernel. The venules are determined if the voxel intensities are lower than the mean signal intensities minus 2 times the standard deviation of the local area [22,38,39]. The locations of individual arteriole/venule voxels defined in the A–V map were used to extract the time courses of BOLD/CBV-fMRI for individual vessels.

BOLD/CBV-fMRI and PC-MRI data analysis

To register the evoked bSSFP-fMRI images and evoked PC-MRI images with the 2D anatomical A–V map, the tag-based registration method was applied. A total of 12 to 15 tags were selected from the averaged bSSFP-fMRI images or the averaged PC-fMRI images to register those selected from the A–V map. We used a 3dLocalstat AFNI function to normalize the signal intensity of the single-vessel maps. This process allowed us to plot the PC-based velocity values of individual vessel voxels to the normalized signal intensity of A–V maps. For the evoked signals, the bSSFP-fMRI images and PC-MRI images were normalized by scaling the baseline to 100. Multiple trials of block design time courses were averaged for each animal. No additional smoothing step was applied. The β-value was calculated to measure the amplitude of the fMRI responses at each TR. The voxel-wise β map was illustrated with the spatial pattern of the fMRI responses corresponding to the different time points after the stimulus onset. After registration (tag-based registration) and region of interest extraction (3dLocalstat function, mask shown in Fig 2B), we extracted the PC-based flow velocity values from individual vessel voxels, which were identified based on the algorithm as described in the previous section.

The hemodynamic response function is based on the “block function” of 3dDeconvolve module developed in AFNI. The HRF model is defined as follows:

h(t)=0min(t,L)s4es/[44e4]ds

Gamma variate function = s4e−s /44e−4. L was the duration of the response. BLOCK (L, 1) is a convolution of a square wave of duration L that makes a peak amplitude of block response = 1.

For the resting-state single-vessel CBFv-fMRI correlation analysis, the seed-based voxel-wise correlation map was created using AFNI. The Welch power spectrum density plot was calculated from arteriole and venule voxels with averaged periodogram method (a 240-second timing window into overlapping sections with 60-point and 25% overlap). The sampling rate of rs-CBFv-fMRI signal is 4 seconds, allowing the analysis of low-frequency signal oscillation less than 0.125 Hz.

For the group analysis, Student t test was performed, and error bars are displayed as the means ± SEM. The p-values < 0.05 were considered statistically significant. The sample size of animal experiments is not previously estimated. No blinding and randomization design was needed in this work.

Supporting information

S1 Fig. The preparation of in vivo experiment for the PC-MRI in 14.1 T.

(A) The flowchart of the in vivo experiment in the 14.1 T scanner. (B) Photograph of the custom-made transceiver surface RF coil. (C) Photograph of the coil position: The coil is glued to the rat skull. (D) The schematic drawing of the rat position inside the MRI holder. (E) Representative images from different views of the FLASH MRI show the ideal coil position. FLASH, fast low angle shot; PC, phase contrast; RF, radio frequency.

(TIFF)

S2 Fig. Phase images from the different representative rats with different TEs and flip angles.

(A) Phase images from a representative rat with different TEs, i.e., 2.75, 3.0, and 3.2 ms. The right panel shows the mean blood flow velocity (mean ± SEM) from left images with NArteriole = 48 and NVenule = 22. (B) Phase images from a representative rat with different flip angles, i.e., 25°, 30°, and 35°. The right panel shows the mean CBFv from left images with NArteriole = 38 and NVenule = 14. The data underlying this figure can be found in S4 Data. CBFv, cerebral blood flow–related velocity; TE, echo time.

(TIFF)

S3 Fig. The bSSFP-based single-vessel BOLD/CBV-fMRI and the PC-based single-vessel CBFv measurement from a representative rat.

(A) The evoked bSSFP-based BOLD- (left) and CBV- (right) fMRI maps overlaid on the A–V map of a representative rat, with the voxel-wise time courses from the ROIs of individual venule and arteriole voxels (10 seconds on and 35 seconds off for 10 epochs plotted in a 3 × 3 matrix). (B) The evoked CBFv functional maps overlaid on the A–V map of a representative rat. The voxel-wise time courses of CBFv changes from the same ROIs of individual venule and arteriole voxels (10 seconds on and 50 seconds off for 12 epochs plotted in a 3 x 3 matrix). A–V, arteriole–venule; BOLD, blood oxygenation level–dependent; bSSFP, balanced steady-state free precession; CBFv, cerebral blood flow–related velocity; CBV, cerebral blood volume; PC, phase contrast; ROI, region of interest.

(TIFF)

S4 Fig. The PC-based single-vessel resting-state CBFv-fMRI mapping.

(A) The A–V map shows bright dot as arterioles and dark dots as venules from one representative rat. Seed-based correlation maps were overlapped on the A–V map, showing 2 venule seeds (V1 and V2) and 2 arteriole seeds (A1 and A2). The venule-based correlation map shows positive correlations to other venules, but negative correlations with arterioles. In contrast, the arteriole-based correlation map shows positive correlations to other arterioles, but negative correlations with venules. (B) The enlarged CBFv map shows the venule with positive velocity (bright dots) and arterioles with negative velocity (dark dots). The venule seed-based CBFv correlation map was overlapped on the CBFv map, showing the positive correlation on surrounding venule voxels (bright dots), and negative correlation on surrounding arteriole voxels (dark dots). (C) The normalized time course extracted from venule and arteriole voxels, showing correlated low-frequency signal fluctuation. (D) The PSD plot of resting state CBFv dynamics from arteriole and venule voxels shows the slightly higher power from 0.01 to 0.04Hz (n = 5). The data underlying this figure can be found in S5 Data. A–V, arteriole–venule; CBFv, cerebral blood flow–related velocity; PC, phase contrast; PSD, power spectrum density.

(TIFF)

S5 Fig. The PC-based CBFv mapping in rats with the 9.4 T scanner.

(A) The vectorized flow velocity (CBFv) map with 67 × 67 um2 in-plane resolution shows venules (bright dots) with positive CBFv values and arterioles (dark dots) with negative CBFv values. (B) The bar graph shows the averaged velocity for arterioles (−1.37 ± 0.94 mm/s) and venules (1.02 ± 0.32 mm/s) from 4 rats. The data underlying this figure can be found in S6 Data. CBFv, cerebral blood flow–related velocity; PC, phase contrast.

(TIFF)

S1 Movie. The bSSFP-based single-vessel BOLD/CBV-fMRI and the PC-MRI based single-vessel CBFv-fMRI in the rat cortex.

The left panel shows the evoked bSSFP-based BOLD- (upper) and CBV- (lower) fMRI responses with a representative trace from single venule and arteriole voxels (arrow) (10 seconds on and 35 seconds off for a total of 45-second time window with TR = 1 second). The right panel shows the evoked PC-based CBFv-fMRI responses with a representative trace from single venule (upper) and arteriole (lower) voxels (10 seconds on and 50 seconds off for a total of 60-second time window with TR = 4 seconds). Note that the underlay is the A–V map showing venules as dark voxels and arterioles as bright voxels. A–V, arteriole–venule; BOLD, blood oxygenation level–dependent; bSSFP, balanced steady-state free precession; CBFv, cerebral blood flow–related velocity; CBV, cerebral blood volume; PC, phase contrast.

(MP4)

S1 Data. The flow velocity estimates from the 5 ROIs with different TEs and different pump rates.

The flow velocity estimates from the 5 ROIs with different TEs (4.2, 4.5, 5.0, and 6.0 ms) and different pump rates (0, 2.3, 4.5, 6.8, and 9 mm/s). The linear fitting is calculated from averaged velocity of venules and arterioles.ROI, region of interest; TE, echo time.

(XLSX)

S2 Data. Scatter plot of the flow velocities from individual arterioles and venules as the function of the normalized signal intensities of each vessel in the A–V map from 11 rats.

Fig 2D upper panel: The flow velocities from individual arterioles and venules as the function of the normalized signal intensities of each vessel in the A–V map. The raw data was acquired from 11 animals. Fig 2D lower panel: Mean velocity of arterioles and venules for the bar graph from 11 animals. MATLAB code and mat file: The MATLAB code and raw data for the histogram of the blood velocity distribution across arterioles and venules from the animals. A–V, arteriole–venule.

(RAR)

S3 Data. Hemodynamic signal data for single-vessel BOLD, CBV, and CBFv-fMRI measurement.

Fig 3B: The time courses of evoked bSSFP-BOLD and CBV-fMRI with the block design stimulation paradigm from venules and arterioles. Fig 3C: The averaged time courses of the fractional change for evoked BOLD and CBV signals from venule and arteriole ROIs and the raw data from 3 animals. Fig 3D: The time courses of the evoked CBFv changes from the arteriole and venule ROIs from both arterioles and venules with the block design stimulation paradigm. Fig 3E: The averaged time courses of the evoked CBFv changes from arteriole and venule ROIs with the block design stimulation paradigm and the raw data from 5 animals. Fig 3F: The venules and arterioles ROIs peak signals for BOLD, CBV, and CBFv measurements from different animals. BOLD, blood oxygenation level–dependent; bSSFP, balanced steady-state free precession; CBFv, cerebral blood flow–related velocity; CBV, cerebral blood volume; ROI, region of interest.

(XLSX)

S4 Data. Blood flow velocity with different TEs and flip angles.

S2A Fig: The blood flow velocity of 48 arterioles and 22 venules with different TEs (2.75, 3.0, and 3.2 ms). S2B Fig: The blood flow velocity of 38 arterioles and 14 venules with different flip angles (25°, 30°, 35°). TE, echo time.

(XLSX)

S5 Data. The PC-based single-vessel resting-state CBFv-fMRI PSD.

The PSD of resting state CBFv dynamics from arteriole and venule voxels from 5 animals. CBFv, cerebral blood flow–related velocity; PC, phase contrast; PSD, power spectrum density.

(XLSX)

S6 Data. The PC-based CBFv mapping in rats with the 9.4 T scanner.

The averaged velocity for arterioles and venules from 4 animals. CBFv, cerebral blood flow–related velocity; PC, phase contrast.

(XLSX)

Acknowledgments

We thank Dr. E. Weiler and Ms. S. Fischer for animal/lab maintenance and support, Dr. N. Avdievitch for technical support, and the Analysis of Functional NeuroImages (AFNI) team for their software support.

Abbreviations

AD

Alzheimer disease

AFNI

Analysis of Functional NeuroImages

ASL

arterial spin labeling

A–V

arteriole–venule

BOLD

blood oxygenation level–dependent

bSSFP

balanced steady-state free precession

CBF

cerebral blood flow

CBFv

cerebral blood flow–related velocity

CBV

cerebral blood volume

CNR

contrast-to-noise ratio

fMRI

functional MRI

MGE

multi-gradient echo

PC

phase contrast

RF

radio frequency

SNR

signal-to-noise ratio

TE

echo time

TR

repetition time

VASO

vascular-space-occupancy

Venc

velocity encoding

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

X.Y. and Y.J. were supported by NIH RF1NS113278, R01NS120594, D.K. was supported by NIH R35NS097265 and R01MH111438, X.C. was supported by the student scholarship from the Chinese Scholarship Council and Deutsche Forschungsgemeinschaft (DFG, Germany Research Foundation) grant YU 215/3-1, K.S. and R.P. were supported by DFG SCHE 658/15, SCHE 658/12. S.C. was supported by Bundesministerium fuer bildung und forschung (BMBF, Federal Ministry of Education and Research) grant 01GQ1702. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Attwell D, Buchan AM, Charpak S, Lauritzen M, MacVicar BA, Newman EA. Glial and neuronal control of brain blood flow. Nature. 2010;468(7321):232–43. doi: 10.1038/nature09613 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Shih AY, Driscoll JD, Drew PJ, Nishimura N, Schaffer CB, Kleinfeld D. Two-photon microscopy as a tool to study blood flow and neurovascular coupling in the rodent brain. J Cereb Blood Flow Metab. 2012;32(7):1277–309. doi: 10.1038/jcbfm.2011.196 ; PubMed Central PMCID: PMC3390800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Kleinfeld D, Mitra PP, Helmchen F, Denk W. Fluctuations and stimulus-induced changes in blood flow observed in individual capillaries in layers 2 through 4 of rat neocortex. Proc Natl Acad Sci U S A. 1998;95(26):15741–6. doi: 10.1073/pnas.95.26.15741 ; PubMed Central PMCID: PMC28114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Srinivasan VJ, Sakadzic S, Gorczynska I, Ruvinskaya S, Wu W, Fujimoto JG, et al. Depth-resolved microscopy of cortical hemodynamics with optical coherence tomography. Opt Lett. 2009;34(20):3086–8. doi: 10.1364/OL.34.003086 ; PubMed Central PMCID: PMC2778254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Yao J, Maslov KI, Shi Y, Taber LA, Wang LV. In vivo photoacoustic imaging of transverse blood flow by using Doppler broadening of bandwidth. Opt Lett. 2010;35(9):1419–21. doi: 10.1364/OL.35.001419 ; PubMed Central PMCID: PMC2916025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Ances BM, Greenberg JH, Detre JA. Laser doppler imaging of activation-flow coupling in the rat somatosensory cortex. NeuroImage. 1999;10(6):716–23. doi: 10.1006/nimg.1999.0510 . [DOI] [PubMed] [Google Scholar]
  • 7.Dunn AK, Bolay H, Moskowitz MA, Boas DA. Dynamic imaging of cerebral blood flow using laser speckle. J Cereb Blood Flow Metab. 2001;21(3):195–201. doi: 10.1097/00004647-200103000-00002 . [DOI] [PubMed] [Google Scholar]
  • 8.Mace E, Montaldo G, Cohen I, Baulac M, Fink M, Tanter M. Functional ultrasound imaging of the brain. Nat Methods. 2011;8(8):662–4. doi: 10.1038/nmeth.1641 . [DOI] [PubMed] [Google Scholar]
  • 9.Sieu LA, Bergel A, Tiran E, Deffieux T, Pernot M, Gennisson JL, et al. EEG and functional ultrasound imaging in mobile rats. Nat Methods. 2015;12(9):831–4. Epub 2015/08/04. doi: 10.1038/nmeth.3506 ; PubMed Central PMCID: PMC4671306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Rungta RL, Osmanski BF, Boido D, Tanter M, Charpak S. Light controls cerebral blood flow in naive animals. Nat Commun. 2017;8:14191. Epub 2017/02/01. doi: 10.1038/ncomms14191; PubMed Central PMCID: PMC5290324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Wang T, Wu C, Ouzounov DG, Gu W, Xia F, Kim M, et al. Quantitative analysis of 1300-nm three-photon calcium imaging in the mouse brain. Elife. 2020;9. Epub 2020/01/31. doi: 10.7554/eLife.53205; PubMed Central PMCID: PMC7028383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Xie Y, Chan AW, McGirr A, Xue S, Xiao D, Zeng H, et al. Resolution of High-Frequency Mesoscale Intracortical Maps Using the Genetically Encoded Glutamate Sensor iGluSnFR. J Neurosci. 2016;36(4):1261–72. Epub 2016/01/29. doi: 10.1523/JNEUROSCI.2744-15.2016 ; PubMed Central PMCID: PMC6604822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ovsepian SV, Jiang Y, Sardella TCP, Malekzadeh-Najafabadi J, Burton NC, Yu X, et al. Visualizing cortical response to optogenetic stimulation and sensory inputs using multispectral handheld optoacoustic imaging. Photodermatology. 2020;17:100153. Epub 2020/03/11. doi: 10.1016/j.pacs.2019.100153; PubMed Central PMCID: PMC7052434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kwong KK, Belliveau JW, Chesler DA, Goldberg IE, Weisskoff RM, Poncelet BP, et al. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci U S A. 1992;89(12):5675–9. doi: 10.1073/pnas.89.12.5675 ; PubMed Central PMCID: PMC49355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Detre JA, Leigh JS, Williams DS, Koretsky AP. Perfusion imaging. Magn Reson Med. 1992;23(1):37–45. doi: 10.1002/mrm.1910230106 . [DOI] [PubMed] [Google Scholar]
  • 16.Williams DS, Detre JA, Leigh JS, Koretsky AP. Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci U S A. 1992;89(1):212–6. Epub 1992/01/01. doi: 10.1073/pnas.89.1.212 ; PubMed Central PMCID: PMC48206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Detre JA, Wang J. Technical aspects and utility of fMRI using BOLD and ASL. Clin Neurophysiol. 2002;113(5):621–34. Epub 2002/04/27. doi: 10.1016/s1388-2457(02)00038-x . [DOI] [PubMed] [Google Scholar]
  • 18.Ogawa S, Lee TM, Kay AR, Tank DW. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A. 1990;87(24):9868–72. doi: 10.1073/pnas.87.24.9868 ; PubMed Central PMCID: PMC55275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ogawa S, Tank DW, Menon R, Ellermann JM, Kim SG, Merkle H, et al. Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging. Proc Natl Acad Sci U S A. 1992;89(13):5951–5. doi: 10.1073/pnas.89.13.5951 ; PubMed Central PMCID: PMC402116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Belliveau JW, Kennedy DN Jr., McKinstry RC, Buchbinder BR, Weisskoff RM, Cohen MS, et al. Functional mapping of the human visual cortex by magnetic resonance imaging. Science. 1991;254(5032):716–9. doi: 10.1126/science.1948051 . [DOI] [PubMed] [Google Scholar]
  • 21.Lu H, Golay X, Pekar JJ, Van Zijl PC. Functional magnetic resonance imaging based on changes in vascular space occupancy. Magn Reson Med. 2003;50(2):263–74. Epub 2003/07/24. doi: 10.1002/mrm.10519 . [DOI] [PubMed] [Google Scholar]
  • 22.Yu X, He Y, Wang M, Merkle H, Dodd SJ, Silva AC, et al. Sensory and optogenetically driven single-vessel fMRI. Nat Methods. 2016;13(4):337–40. doi: 10.1038/nmeth.3765 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Huber L, Handwerker DA, Jangraw DC, Chen G, Hall A, Stuber C, et al. High-Resolution CBV-fMRI Allows Mapping of Laminar Activity and Connectivity of Cortical Input and Output in Human M1. Neuron. 2017;96(6):1253–63 e7. Epub 2017/12/12. doi: 10.1016/j.neuron.2017.11.005 ; PubMed Central PMCID: PMC5739950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Park SH, Do WJ, Choi SH, Zhao T, Bae KT. Mapping blood flow directionality in the human brain. Magn Reson Imaging. 2016;34(6):754–64. Epub 2016/03/13. doi: 10.1016/j.mri.2016.03.005 . [DOI] [PubMed] [Google Scholar]
  • 25.Frank LR, Lu K, Wong EC. Perfusion tensor imaging. Magn Reson Med. 2008;60(6):1284–91. Epub 2008/11/26. doi: 10.1002/mrm.21806 ; PubMed Central PMCID: PMC4319714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Wong EC, Cronin M, Wu WC, Inglis B, Frank LR, Liu TT. Velocity-selective arterial spin labeling. Magn Reson Med. 2006;55(6):1334–41. Epub 2006/05/16. doi: 10.1002/mrm.20906 . [DOI] [PubMed] [Google Scholar]
  • 27.Wu WC, Wong EC. Feasibility of velocity selective arterial spin labeling in functional MRI. J Cereb Blood Flow Metab. 2007;27(4):831–8. Epub 2006/08/24. doi: 10.1038/sj.jcbfm.9600386 . [DOI] [PubMed] [Google Scholar]
  • 28.Moran PR. A flow velocity zeugmatographic interlace for NMR imaging in humans. Magn Reson Imaging. 1982;1(4):197–203. Epub 1982/01/01. doi: 10.1016/0730-725x(82)90170-9 . [DOI] [PubMed] [Google Scholar]
  • 29.Bryant DJ, Payne JA, Firmin DN, Longmore DB. Measurement of flow with NMR imaging using a gradient pulse and phase difference technique. J Comput Assist Tomogr. 1984;8(4):588–93. Epub 1984/08/01. doi: 10.1097/00004728-198408000-00002 . [DOI] [PubMed] [Google Scholar]
  • 30.Zong X, Lin W. Quantitative phase contrast MRI of penetrating arteries in centrum semiovale at 7T. NeuroImage. 2019;195:463–74. Epub 2019/04/03. doi: 10.1016/j.neuroimage.2019.03.059 . [DOI] [PubMed] [Google Scholar]
  • 31.Bouvy WH, Geurts LJ, Kuijf HJ, Luijten PR, Kappelle LJ, Biessels GJ, et al. Assessment of blood flow velocity and pulsatility in cerebral perforating arteries with 7-T quantitative flow MRI. NMR Biomed. 2016;29(9):1295–304. Epub 2015/04/29. doi: 10.1002/nbm.3306 ; PubMed Central PMCID: PMC5008170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Kang CK, Park CA, Lee DS, Lee YB, Park CW, Kim YB, et al. Velocity measurement of microvessels using phase-contrast magnetic resonance angiography at 7 Tesla MRI. Magn Reson Med. 2016;75(4):1640–6. Epub 2015/05/20. doi: 10.1002/mrm.25600 . [DOI] [PubMed] [Google Scholar]
  • 33.Schnerr RS, Jansen JFA, Uludag K, Hofman PAM, Wildberger JE, van Oostenbrugge RJ, et al. Pulsatility of Lenticulostriate Arteries Assessed by 7 Tesla Flow MRI-Measurement, Reproducibility, and Applicability to Aging Effect. Front Physiol. 2017;8:961. Epub 2017/12/12. doi: 10.3389/fphys.2017.00961; PubMed Central PMCID: PMC5705621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Wei Z, Chen L, Lin Z, Jiang D, Xu J, Liu P, et al. Optimization of phase-contrast MRI for the estimation of global cerebral blood flow of mice at 11.7T. Magn Reson Med. 2019;81(4):2566–75. Epub 2018/11/06. doi: 10.1002/mrm.27592 ; PubMed Central PMCID: PMC6372341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Dolui S, Wang Z, Wang DJJ, Mattay R, Finkel M, Elliott M, et al. Comparison of non-invasive MRI measurements of cerebral blood flow in a large multisite cohort. J Cereb Blood Flow Metab. 2016;36(7):1244–56. Epub 2016/05/05. doi: 10.1177/0271678X16646124 ; PubMed Central PMCID: PMC4929707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Geurts LJ, Bhogal AA, Siero JCW, Luijten PR, Biessels GJ, Zwanenburg JJM. Vascular reactivity in small cerebral perforating arteries with 7T phase contrast MRI—A proof of concept study. NeuroImage. 2018;172:470–7. Epub 2018/02/07. doi: 10.1016/j.neuroimage.2018.01.055 ; PubMed Central PMCID: PMC5915583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Hoogeveen RM, Bakker CJ, Viergever MA. MR phase-contrast flow measurement with limited spatial resolution in small vessels: value of model-based image analysis. Magn Reson Med. 1999;41(3):520–8. Epub 1999/04/16. doi: . [DOI] [PubMed] [Google Scholar]
  • 38.He Y, Wang M, Chen X, Pohmann R, Polimeni JR, Scheffler K, et al. Ultra-Slow Single-Vessel BOLD and CBV-Based fMRI Spatiotemporal Dynamics and Their Correlation with Neuronal Intracellular Calcium Signals. Neuron. 2018;97(4):925–39 e5. Epub 2018/02/06. doi: 10.1016/j.neuron.2018.01.025 ; PubMed Central PMCID: PMC5845844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Chen X, Sobczak F, Chen Y, Jiang Y, Qian C, Lu Z, et al. Mapping optogenetically-driven single-vessel fMRI with concurrent neuronal calcium recordings in the rat hippocampus. Nat Commun. 2019;10(1):5239. doi: 10.1038/s41467-019-12850-x; PubMed Central PMCID: PMC6868210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Walker PG, Cranney GB, Scheidegger MB, Waseleski G, Pohost GM, Yoganathan AP. Semiautomated method for noise reduction and background phase error correction in MR phase velocity data. J Magn Reson Imaging. 1993;3(3):521–30. Epub 1993/05/01. doi: 10.1002/jmri.1880030315 . [DOI] [PubMed] [Google Scholar]
  • 41.Peeters JM, Bos C, Bakker CJ. Analysis and correction of gradient nonlinearity and B0 inhomogeneity related scaling errors in two-dimensional phase contrast flow measurements. Magn Reson Med. 2005;53(1):126–33. Epub 2005/02/04. doi: 10.1002/mrm.20309 . [DOI] [PubMed] [Google Scholar]
  • 42.Bernstein MA, Zhou XJ, Polzin JA, King KF, Ganin A, Pelc NJ, et al. Concomitant gradient terms in phase contrast MR: analysis and correction. Magn Reson Med. 1998;39(2):300–8. Epub 1998/02/20. doi: 10.1002/mrm.1910390218 . [DOI] [PubMed] [Google Scholar]
  • 43.Schaffer CB, Friedman B, Nishimura N, Schroeder LF, Tsai PS, Ebner FF, et al. Two-photon imaging of cortical surface microvessels reveals a robust redistribution in blood flow after vascular occlusion. PLoS Biol. 2006;4(2):e22. Epub 2005/12/29. doi: 10.1371/journal.pbio.0040022; PubMed Central PMCID: PMC1324794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Shih AY, Blinder P, Tsai PS, Friedman B, Stanley G, Lyden PD, et al. The smallest stroke: occlusion of one penetrating vessel leads to infarction and a cognitive deficit. Nat Neurosci. 2013;16(1):55–63. Epub 2012/12/18. doi: 10.1038/nn.3278 ; PubMed Central PMCID: PMC3952571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Silva AC, Koretsky AP, Duyn JH. Functional MRI impulse response for BOLD and CBV contrast in rat somatosensory cortex. Magn Reson Med. 2007;57(6):1110–8. doi: 10.1002/mrm.21246 PubMed PMID: WOS:000246979900015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Drew PJ, Shih AY, Kleinfeld D. Fluctuating and sensory-induced vasodynamics in rodent cortex extend arteriole capacity. Proc Natl Acad Sci U S A. 2011;108(20):8473–8. doi: 10.1073/pnas.1100428108 ; PubMed Central PMCID: PMC3100929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Rungta RL, Chaigneau E, Osmanski BF, Charpak S. Vascular Compartmentalization of Functional Hyperemia from the Synapse to the Pia. Neuron. 2018;99(2):362–75 e4. Epub 2018/06/26. doi: 10.1016/j.neuron.2018.06.012 ; PubMed Central PMCID: PMC6069674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Koretsky AP. Early development of arterial spin labeling to measure regional brain blood flow by MRI. NeuroImage. 2012;62(2):602–7. Epub 2012/01/17. doi: 10.1016/j.neuroimage.2012.01.005 ; PubMed Central PMCID: PMC4199083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Wang J, Fernandez-Seara MA, Wang S, St Lawrence KS. When perfusion meets diffusion: in vivo measurement of water permeability in human brain. J Cereb Blood Flow Metab. 2007;27(4):839–49. Epub 2006/09/14. doi: 10.1038/sj.jcbfm.9600398 . [DOI] [PubMed] [Google Scholar]
  • 50.Hutchinson EB, Stefanovic B, Koretsky AP, Silva AC. Spatial flow-volume dissociation of the cerebral microcirculatory response to mild hypercapnia. NeuroImage. 2006;32(2):520–30. doi: 10.1016/j.neuroimage.2006.03.033 . [DOI] [PubMed] [Google Scholar]
  • 51.Kobat D, Durst ME, Nishimura N, Wong AW, Schaffer CB, Xu C. Deep tissue multiphoton microscopy using longer wavelength excitation. Opt Express. 2009;17(16):13354–64. doi: 10.1364/oe.17.013354 [DOI] [PubMed] [Google Scholar]
  • 52.Kobat D, Horton NG, Xu C. In vivo two-photon microscopy to 1.6-mm depth in mouse cortex. J Biomed Opt. 2011;16(10):106014. Epub 2011/10/28. doi: 10.1117/1.3646209. [DOI] [PubMed] [Google Scholar]
  • 53.Drew PJ, Shih AY, Driscoll JD, Knutsen PM, Blinder P, Davalos D, et al. Chronic optical access through a polished and reinforced thinned skull. Nat Methods. 2010;7(12):981–4. Epub 2010/10/23. doi: 10.1038/nmeth.1530 ; PubMed Central PMCID: PMC3204312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Xu HT, Pan F, Yang G, Gan WB. Choice of cranial window type for in vivo imaging affects dendritic spine turnover in the cortex. Nat Neurosci. 2007;10(5):549–51. Epub 2007/04/10. doi: 10.1038/nn1883 . [DOI] [PubMed] [Google Scholar]
  • 55.Dorand RD, Barkauskas DS, Evans TA, Petrosiute A, Huang AY. Comparison of intravital thinned skull and cranial window approaches to study CNS immunobiology in the mouse cortex. Intravital. 2014;3(2). Epub 2015/01/09. doi: 10.4161/intv.29728; PubMed Central PMCID: PMC4283137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Cole JT, Yarnell A, Kean WS, Gold E, Lewis B, Ren M, et al. Craniotomy: true sham for traumatic brain injury, or a sham of a sham? J Neurotrauma. 2011;28(3):359–69. Epub 2010/12/31. doi: 10.1089/neu.2010.1427 ; PubMed Central PMCID: PMC3057208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Davis TL, Kwong KK, Weisskoff RM, Rosen BR. Calibrated functional MRI: mapping the dynamics of oxidative metabolism. Proc Natl Acad Sci U S A. 1998;95(4):1834–9. Epub 1998/03/21. doi: 10.1073/pnas.95.4.1834 ; PubMed Central PMCID: PMC19199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Leontiev O, Dubowitz DJ, Buxton RB. CBF/CMRO2 coupling measured with calibrated BOLD fMRI: sources of bias. NeuroImage. 2007;36(4):1110–22. Epub 2007/05/26. doi: 10.1016/j.neuroimage.2006.12.034 ; PubMed Central PMCID: PMC2038985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Mateo C, Knutsen PM, Tsai PS, Shih AY, Kleinfeld D. Entrainment of Arteriole Vasomotor Fluctuations by Neural Activity Is a Basis of Blood-Oxygenation-Level-Dependent "Resting-State" Connectivity. Neuron. 2017;96(4):936–48 e3. doi: 10.1016/j.neuron.2017.10.012 ; PubMed Central PMCID: PMC5851777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.van Veluw SJ, Hou SS, Calvo-Rodriguez M, Arbel-Ornath M, Snyder AC, Frosch MP, et al. Vasomotion as a Driving Force for Paravascular Clearance in the Awake Mouse Brain. Neuron. 2020;105(3):549–61 e5. Epub 2019/12/08. doi: 10.1016/j.neuron.2019.10.033 ; PubMed Central PMCID: PMC7028316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Wagshul ME, Eide PK, Madsen JR. The pulsating brain: A review of experimental and clinical studies of intracranial pulsatility. Fluids Barriers CNS. 2011;8(1):5. Epub 2011/02/26. doi: 10.1186/2045-8118-8-5; PubMed Central PMCID: PMC3042979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Driver ID, Traat M, Fasano F, Wise RG. Most Small Cerebral Cortical Veins Demonstrate Significant Flow Pulsatility: A Human Phase Contrast MRI Study at 7T. Front Neurosci. 2020;14:415. Epub 2020/05/21. doi: 10.3389/fnins.2020.00415; PubMed Central PMCID: PMC7214844. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Lucas Smith

28 Aug 2020

Dear Dr Yu,

Thank you for submitting your manuscript entitled "Single-vessel cerebral blood flow fMRI to map blood velocity by phase-contrast imaging" for consideration as a Methods and Resources by PLOS Biology.

Your manuscript has now been evaluated by the PLOS Biology editorial staff as well as by an academic editor with relevant expertise and I am writing to let you know that we would like to send your submission out for external peer review.

However, before we can send your manuscript to reviewers, we need you to complete your submission by providing the metadata that is required for full assessment. To this end, please login to Editorial Manager where you will find the paper in the 'Submissions Needing Revisions' folder on your homepage. Please click 'Revise Submission' from the Action Links and complete all additional questions in the submission questionnaire.

Please re-submit your manuscript within two working days, i.e. by Aug 30 2020 11:59PM.

Login to Editorial Manager here: https://www.editorialmanager.com/pbiology

During resubmission, you will be invited to opt-in to posting your pre-review manuscript as a bioRxiv preprint. Visit http://journals.plos.org/plosbiology/s/preprints for full details. If you consent to posting your current manuscript as a preprint, please upload a single Preprint PDF when you re-submit.

Once your full submission is complete, your paper will undergo a series of checks in preparation for peer review. Once your manuscript has passed all checks it will be sent out for review.

Given the disruptions resulting from the ongoing COVID-19 pandemic, please expect delays in the editorial process. We apologise in advance for any inconvenience caused and will do our best to minimize impact as far as possible.

Feel free to email us at plosbiology@plos.org if you have any queries relating to your submission.

Kind regards,

Lucas Smith, Ph.D.,

Associate Editor

PLOS Biology

Decision Letter 1

Lucas Smith

29 Oct 2020

Dear Dr Yu,

Thank you very much for submitting your manuscript "Single-vessel cerebral blood flow fMRI to map blood velocity by phase-contrast imaging" for consideration as a Methods and Resources at PLOS Biology. Your manuscript has been evaluated by the PLOS Biology editors, an Academic Editor with relevant expertise, and by several independent reviewers.

The reviews of your manuscript are appended below. As you will see from their comments, the reviewers have raised a number of specific points that need to be addressed to strengthen the study before we can consider it for publication at PLOS Biology. For example, reviewer 1 would like additional clarifications on the velocity measurements and reviewer 2 has noted potential limitations of the PC-MRI approach that are not addressed. Importantly, reviewer 2 considers that the manuscript does not currently demonstrate the advantage of the PC-MRI approach over existing methods for either basic or clinical researchers, or demonstrate the potential to experimentally address a previously inaccessible biological question. These are requirements for PLOS Biology Methods and Resources articles. A revised manuscript would need to demonstrate an advantage over existing methods and/or how it can be implemented to gain previously elusive biological insights to make a strong case for publication here.

In light of the reviews, we will not be able to accept the current version of the manuscript, but we would welcome re-submission of a much-revised version that takes into account the reviewers' comments. We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent for further evaluation by the reviewers

We expect to receive your revised manuscript within 3 months. However, please let us know if you would like an extension, as it is important that the revised manuscript thoroughly addresses the reviewer concerns.

Please email us (plosbiology@plos.org) if you have any questions or concerns, or would like to request an extension. At this stage, your manuscript remains formally under active consideration at our journal; please notify us by email if you do not intend to submit a revision so that we may end consideration of the manuscript at PLOS Biology.

**IMPORTANT - SUBMITTING YOUR REVISION**

Your revisions should address the specific points made by each reviewer. Please submit the following files along with your revised manuscript:

1. A 'Response to Reviewers' file - this should detail your responses to the editorial requests, present a point-by-point response to all of the reviewers' comments, and indicate the changes made to the manuscript.

*NOTE: In your point by point response to the reviewers, please provide the full context of each review. Do not selectively quote paragraphs or sentences to reply to. The entire set of reviewer comments should be present in full and each specific point should be responded to individually, point by point.

You should also cite any additional relevant literature that has been published since the original submission and mention any additional citations in your response.

2. In addition to a clean copy of the manuscript, please also upload a 'track-changes' version of your manuscript that specifies the edits made. This should be uploaded as a "Related" file type.

*Re-submission Checklist*

When you are ready to resubmit your revised manuscript, please refer to this re-submission checklist: https://plos.io/Biology_Checklist

To submit a revised version of your manuscript, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' where you will find your submission record.

Please make sure to read the following important policies and guidelines while preparing your revision:

*Published Peer Review*

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:

https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/

*PLOS Data Policy*

Please note that as a condition of publication PLOS' data policy (http://journals.plos.org/plosbiology/s/data-availability) requires that you make available all data used to draw the conclusions arrived at in your manuscript. If you have not already done so, you must include any data used in your manuscript either in appropriate repositories, within the body of the manuscript, or as supporting information (N.B. this includes any numerical values that were used to generate graphs, histograms etc.). For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5

*Blot and Gel Data Policy*

We require the original, uncropped and minimally adjusted images supporting all blot and gel results reported in an article's figures or Supporting Information files. We will require these files before a manuscript can be accepted so please prepare them now, if you have not already uploaded them. Please carefully read our guidelines for how to prepare and upload this data: https://journals.plos.org/plosbiology/s/figures#loc-blot-and-gel-reporting-requirements

*Protocols deposition*

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosbiology/s/submission-guidelines#loc-materials-and-methods

Thank you again for your submission to our journal. We hope that our editorial process has been constructive thus far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Lucas Smith, Ph.D.,

Associate Editor,

lsmith@plos.org,

PLOS Biology

*****************************************************

REVIEWS:

Reviewer's Responses to Questions

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes: Cornelius Faber

Reviewer #1: This paper is a follow up from their previous work which elegantly demonstrated single vessel BOLD and CBV -fMRI. Here they extend this platform to include single vessel velocity measurements using high-resolution phase-contrast MRI. This is a powerful technique with potential applications towards high-resolution imaging in humans and understanding hemodynamic responses in animal models. The authors capture single vessel signals for BOLD, CBV and velocity across single trials. I am enthusiastic about the study, but I do have a couple concerns.

1. Flow and velocity are intermixed throughout the manuscript which is confusing. I would prefer the authors avoid the use of flow to describe velocity. CBF is the quantity/time (eg. ml/min, RBCs/second) whereas velocity is the distance/time. I also suggest changing the name from CBF-fMRI to something else.

2. Upon stimulation, it is surprising that the velocity seems to increase equally in both the arteriole and the veins. Due to the arteriole specific volume increase, I would expect a smaller velocity change in the arteriole than the veins. Previous work in olfactory bulb (PMID: 29937277), demonstrated such a phenomenon with two-photon measurements of vessel diameter and velocity. Do the authors ever see mismatches between volume and velocity with their technique?

3. Can the authors be confident the technique accurately reports absolute velocity? The velocities they report seem very slow when compared to previous measurements of arteriole RBC velocity with two-photon scanning, (e.g. PMID: 19174826, Fig 1). From Fig 2D it appears single arteriole velocities of >3mm/s were only observed in 1 of 6 rats and no arterioles had velocities above 5mm/s. In Figure S2 Rat#2 has a mean arteriole velocity of <0.5mm/s (38 arterioles). Could there be contamination from tissue parenchyma, interstitial fluid, and surrounding capillary bed? The authors state possible partial volume effects in the last sentence of the discussion. But it would be important to clearly state how this may affect the quantitative measurements being made to avoid misinterpretation of the results.

Minor:

Fig 2C, could the authors add a velocity scale bar.

L97 - typo, "while" matter

Reviewer #2: This manuscript describes the use of phase contrast MRI (PC-MRI) for detecting velocity and velocity changes in signal cortical arteries and veins in the rat brain. High resolution PC MRI was performed at 14.1 T in anesthetized rats and compared to BOLD fMRI and contrast-enhanced CBV based fMRI for detecting functional activation during forepaw stimulation. Whereas BOLD fMRI was more sensitive to venules than arterioles and CBV MRI was more sensitive to arterioles than venules, PC-MRI sensitivity was comparable between venules and arterioles. The authors conclude that the method will be useful for studying disease models and can be translated to human use for studying vascular dementia and other brain disorders. While the methods and resulting data are reasonable, the main novelty of the work is carrying out PC-MRI at higher resolution than has been used previously while the rationale and implications of the method are poorly developed and its limitations are inadequately discussed. The manuscript could be improved by consideration of the following issues, all of which are essential to improving the work:

1. The first sentence of the introduction describes CBF as a "key readout of neuronal processing." That is not strictly correct. Through neurovascular coupling, CBF is coupled to neural and not neuronal activity. It is less clear whether neuronal processing (spike patterns, etc.) are tightly linked to CBF changes.

2. CBF generally refers to a quantifiable metric of flow, either in ml/min or ml/g/min. In the current work and much of the first paragraph of the introduction, the authors are referring to flow or changes in flow and not quantified CBF. For example, NIRS certainly does not measure CBF. It measures changes in oxyhemoglobin/deoxyhemoglobin ratios that may reflect underlying changes in CBF.

3. The discussion of flow sensitive methods leaves out vascular space occupancy (VASO) contrast.

4. (line 95) The authors are incorrect that ASL cannot show orientation-specific effects. Because continuous arterial spin labeling methods leverage directional flow, they contain directional information (see e.g. https://pubmed.ncbi.nlm.nih.gov/26968145/)

5. (lines 141-1) All PC MRI is single vessel, so this sentence should be modified to contain information about the type of vessels.

6. (line 153) The manuscript describes results on "stimulation" without describing the nature of the stimulus. Although that is covered in the Methods, given the organization of the manuscript with the methods at the end, the Results should be more descriptive.

7. Figure 3D is never described in the text of the manuscript. Figure 3E uses a different timing on the x-axis from 3C, which makes comparisons more difficult than it needs to be. The authors might also consider flipping the CBV and arteriolar plots in Figures B-E along the y-axis so that the changes show the same polarity as the other plots.

8. The supplemental movie is also difficult to follow.

9. Although a number of rats were studied with multiple contrast mechanisms, there does not appear to be any statistical treatment of the data.

10. The authors state in the Discussion and elsewhere that they have "optimized" PC-MRI in this work, but no optimization is presented.

11. One of the main weaknesses of this manuscript is the failure to address limitations of the PC-MRI approach. Firstly, because velocity encoding is directional in PC-MRI, it is sensitive to the angle of the vessel with respect to the velocity encoding gradient. Accordingly, the measured velocity changes will vary with this angle. While there may be literature demonstrating that cortical microvessels are largely orthogonal to the cortical surface, which could minimize such errors, this issue should be addressed. Even if it is true that cortical microvessels are orthogonal to the surface, the cortical surface is curved and the imaging slab is not. A second issue is that while imaging resolution is very high (50 microns) in-plane, the imaging slab is an order of magnitude larger. So, there are also likely significant partial volume effects in this approach. Both of these limitations undermine accurate quantification of flow changes.

12. Perhaps the biggest weakness of the manuscript is the failure to address the significance of PC-MRI versus existing methods for studying cortical function. While the authors demonstrate that PC-MRI is roughly equally sensitive to both arteriolar and venular flow changes, they don't say why this is advantageous for either basic or clinical research studies of regional brain function. They also do not address the challenges in translating this approach to human studies where fields strengths are lower, the cortical surface is further from the RF coil, and subjects are not paralyzed to minimize motion. Accordingly, there is zero basis in the manuscript for the conclusion that the method has translational potential for identifying vascular dementia, or what its potential advantages are as compared to existing methods. Indeed, based on Figure 3 it would appear that using PC-MRI to identify voxels of interest for BOLD contrast changes might provide superior data quality to dynamic PC-MRI. Thus, the potential to experimentally address a previously inaccessible biological question is not demonstrated in this work.

Reviewer #3: In this work the authors have implemented and evaluated a magnetic resoance imaging (MRI) method to measure cerebral blood flow (CBF) with singel vessel resolution in the rat brain, based on the phase contrast (PC) technique. This method complements and is a valuable addition to the established BOLD and CBV techniques to assess brain function by MRI. The authors have previously pioneered single vessel fMRI, and now combine their recent methods with PC-MRI. The novel method is a valuable asset for functional brain imaging and may help to further understand mechanisms of neurovascular coupling and brain function in general.

The work is carefully conducted, the manuscript well written, and of great relevance and interest to the fMRI neuroiamging community. However, for a wider readership, the paper may be too detailed.

While I have no major points that would have to be addressed before the paper can be published, I think a few clarifications concerning reproducibility and possible applications are necessary:

1. The measurements were conducted at 14.1 tesla, a magentic field strength that is not available in most labs. Will this method also be feasible atthe more common 7 tesla or 9.4 tesla?

2. Which pulse program/MR sequence did the authors use; was it the sequence provided by the vendor Bruker?

3. For replication of these experiments, details such as the exact sequence and gradient timing (and ramps) are important. Is it possible to share these details perhaps even the source code of the method (in a supplement)?

4. Are the data presented in Fig. 2D values from single voxels or were they averaged (over how many voxels)? Figure S3 creates the impression that single vessels spread over five to nine voxels.

5. What is the minimum vessel diameter that can be analysed with the presented method? How would this be different at other field strengths or in humans? What was the average vessel diameter in this study?

6. In line 210 the author speculate on a translational potential. How can his method be translated? Is single vessel-CBF feasible in humans? What field strength would be required?

Typos:

l97: "white matter"

l275: missing "were"

Legend to Fig. 3: check for use of direct articles.

Decision Letter 2

Lucas Smith

8 Jul 2021

Dear Dr Yu,

Thank you for submitting your revised Methods and Resources entitled "Single-vessel cerebral blood velocity fMRI based on phase-contrast imaging" for publication in PLOS Biology. I have now obtained advice from the original reviewers and have discussed their comments with the Academic Editor. 

The reviews are appended below. As you will see, reviewers 1 and 3 are completely satisfied by the revision and think the manuscript has been substantially improved. Reviewer 2 also has commented that the revision has addressed many of his/her concerns, but notes that the manuscript should be thoroughly edited for grammar and for clarity.

Based on the reviews, we will probably accept this manuscript for publication, provided you satisfactorily address the remaining points raise by the reviewer 2 and carefully edit the manuscript for English syntax. IMPORTANT: Please also make sure to address the following data and other policy-related requests:

1) Ethics request: In the methods section of your manuscript, please also include an approval number for the animal care and use protocol approved by the Regierungspraesidium, Tübingen Referat 35, Veterinärwesen, Leiter Dr. Maas.

2) Data request: We note that your data availability statement states “Data are available from the Max Planck Institutional Data Access / Ethics Committee for researchers who meet the criteria for access to confidential data”. You may be aware of PLOS' Data Availability Policy (https://journals.plos.org/plosbiology/s/data-availability), which requires that all data be made available without restriction. In order to be compliant with our data availability policy, we will need you to provide the data underlying each figure, as either a supplementary data file or as a deposition in a publicly available repository. Please find the specific details of this request, in the ‘DATA POLICY’ section below my signature. **When addressing this request, you will also need to update your data availability statement to convey where the underlying data can be found. Please also add a sentence to each relevant figure legend (including supplemental) referencing the supplemental file or repository where the underlying data can be found - for example you can add the sentence "The data underlying this figure can be found in S1_data".

3) Scale bars: Please provide scale bars for all figures in which images are shown.

4) Title: Having discussed the title of your manuscript with my colleagues, we wonder if it might be edited slightly to improve clarity. If you agree, we might suggest that you change it to something like "Assessment of single-vessel cerebral blood velocity by phase contrast fMRI".

As you address these items, please take this last chance to review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the cover letter that accompanies your revised manuscript.

We expect to receive your revised manuscript within two weeks.

To submit your revision, please go to https://www.editorialmanager.com/pbiology/ and log in as an Author. Click the link labelled 'Submissions Needing Revision' to find your submission record. Your revised submission must include the following:

-  a cover letter that should detail your responses to any editorial requests, if applicable, and whether changes have been made to the reference list

-  a Response to Reviewers file that provides a detailed response to the reviewers' comments (if applicable)

-  a track-changes file indicating any changes that you have made to the manuscript. 

NOTE: If Supporting Information files are included with your article, note that these are not copyedited and will be published as they are submitted. Please ensure that these files are legible and of high quality (at least 300 dpi) in an easily accessible file format. For this reason, please be aware that any references listed in an SI file will not be indexed. For more information, see our Supporting Information guidelines:

https://journals.plos.org/plosbiology/s/supporting-information  

*Published Peer Review History*

Please note that you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. Please see here for more details:

https://blogs.plos.org/plos/2019/05/plos-journals-now-open-for-published-peer-review/

*Early Version*

Please note that an uncorrected proof of your manuscript will be published online ahead of the final version, unless you opted out when submitting your manuscript. If, for any reason, you do not want an earlier version of your manuscript published online, uncheck the box. Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us as soon as possible if you or your institution is planning to press release the article.

*Protocols deposition*

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please do not hesitate to contact me should you have any questions.

Sincerely,

Lucas Smith, Ph.D.,

Associate Editor,

lsmith@plos.org,

PLOS Biology

------------------------------------------------------------------------

ETHICS STATEMENT:

-- Please include an approval number of the animal care and use protocol/permit/project license approved by the Regierungspraesidium, Tübingen Referat 35, Veterinärwesen, Leiter Dr. Maas.

------------------------------------------------------------------------

DATA POLICY:

You may be aware of the PLOS Data Policy, which requires that all data be made available without restriction: http://journals.plos.org/plosbiology/s/data-availability. For more information, please also see this editorial: http://dx.doi.org/10.1371/journal.pbio.1001797

Note that we do not require all raw data. Rather, we ask that all individual quantitative observations that underlie the data summarized in the figures and results of your paper be made available in one of the following forms:

1) Supplementary files (e.g., excel). Please ensure that all data files are uploaded as 'Supporting Information' and are invariably referred to (in the manuscript, figure legends, and the Description field when uploading your files) using the following format verbatim: S1 Data, S2 Data, etc. Multiple panels of a single or even several figures can be included as multiple sheets in one excel file that is saved using exactly the following convention: S1_Data.xlsx (using an underscore).

2) Deposition in a publicly available repository. Please also provide the accession code or a reviewer link so that we may view your data before publication.

Regardless of the method selected, please ensure that you provide the individual numerical values that underlie the summary data displayed in the following figure panels as they are essential for readers to assess your analysis and to reproduce it:

Figure 1C; Figure 2D; Figure 3 B-F; Figure S2A-B; Figure S4C-D; Figure S5B;

NOTE: the numerical data provided should include all replicates AND the way in which the plotted mean and errors were derived (it should not present only the mean/average values).

Please also ensure that figure legends in your manuscript include information on where the underlying data can be found, and ensure your supplemental data file/s has a legend.

Please ensure that your Data Statement in the submission system accurately describes where your data can be found.

------------------------------------------------------------------------

Reviewer #1, Ravi L. Rungta: The authors have addressed my comments and I congratulate them on a nice technical study. I support the paper for publication.

Reviewer #2: The revised manuscript has addressed many of my concerns, and is also supported by new data. The findings of this study remain interesting. However, some of the modifications to the manuscript still need to be revised for clarity. The manuscript also needs careful editing for English syntax.

1. Line 221: "focal" RF coil should be "local" RF coil

2. Line 223: "diameter" (or radius) is missing from this sentence

3. Line 230-234: The paragraph beginning "In contrast to the T2* weighted resting-state" leads the reader to expect something about differing contrast mechanisms, but the sentence winds up being about frequency (CBFv signal fluctuation … has seldom been directly measured …" Why is this statement in the middle of a paragraph about MRI-based CMRO2 measurements? Is there really a need to mention that their novel approach has been used less often than the most widely used approach?

4. Lines 234-237: Then this same paragraph concludes with a sentence suggesting that this approach can be used to study glymphatic function without explaining how. Paragraphs should have clear themes.

5. Line 238: The next paragraph switches to hardware limitations of phantom studies, but without clearly indicating that except through saying "phantom capillary tubing". Paragraphs should have clear themes.

6. Lines 251-253: This sentence seems to be addressing partial volume effects, but doesn't ever say that directly.

7. Lines 258-267: This paragraph appears to be an effort to respond to the need for better description of the translational (to humans) potential of this method, but the first two sentences discuss animal studies at 9.4T, the third sentence discusses a different type of human functional PC study. The fourth sentence mentions "the pulsation" as a potential confound without explaining what that is, and the last sentence mentions some technical challenges without explaining why they are important.

8. Also, in response to Reviewer 1, the authors have replaced "CBF-fMRI" to "CBFv" which is at best minimally better that CBF-fMRI in differentiating the PC MRI measure (velocity) from CBF.

Reviewer #3, Cornelius Faber: The authors have satisfactorily addressed all points I had raised in my original review. The revised manuscript has improved substantially. I have no further comments.

Decision Letter 3

Lucas Smith

28 Jul 2021

Dear Dr Yu,

On behalf of my colleagues and the Academic Editor, Aniruddha Das, I am pleased to say that we can in principle offer to publish your Methods and Resources "Assessment of single-vessel cerebral blood velocity by phase contrast fMRI" in PLOS Biology, provided you address any remaining formatting and reporting issues. These will be detailed in an email that will follow this letter and that you will usually receive within 2-3 business days, during which time no action is required from you. Please note that we will not be able to formally accept your manuscript and schedule it for publication until you have made the required changes.

Your manuscript has been evaluated by the editorial team and the Academic Editor, and overall we are largely satisfied by your response to the reviewers and our previous editorial requests. However, we do have two additional and minor editorial requests which we need you to address along with the formatting and reporting requests which that are soon to come.

IMPORTANT: Please address the following points:

1) Thank you for providing, as supplementary files, the data underling your figures. As you make the final edits to your manuscript, we additionally ask that you add a sentence to each figure legend (including supplemental) referencing the supplemental file where the underlying data can be found. For example you can add the sentence "The data underlying this figure can be found in supplementary file ‘Main_Figure_data’".

2) We think the sentence starting on line 261 ("Previously, we detected low-frequency fluctuation of single-vessel resting state BOLD fMRI signals (TR = 1 s) from individual sulcus veins and arteries in the occipital lobe of the human brain [38], bearing the interference of pulsation and other motion effects.) requires editing for clarity. In particular, the meaning of 'bearing the interference of pulsation..." is unclear. Do you mean barring? resulting from? Additionally, we think the segue to the next sentence is similarly unclear: "Different from ..." and would be worth clarifying.

Please take a minute to log into Editorial Manager at http://www.editorialmanager.com/pbiology/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production process.

PRESS

We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with biologypress@plos.org. If you have not yet opted out of the early version process, we ask that you notify us immediately of any press plans so that we may do so on your behalf.

We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit http://www.plos.org/about/media-inquiries/embargo-policy/.

Thank you again for choosing PLOS Biology for publication and supporting Open Access publishing. We look forward to publishing your study. 

Sincerely, 

Lucas Smith, Ph.D. 

Senior Editor 

PLOS Biology

lsmith@plos.org

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. The preparation of in vivo experiment for the PC-MRI in 14.1 T.

    (A) The flowchart of the in vivo experiment in the 14.1 T scanner. (B) Photograph of the custom-made transceiver surface RF coil. (C) Photograph of the coil position: The coil is glued to the rat skull. (D) The schematic drawing of the rat position inside the MRI holder. (E) Representative images from different views of the FLASH MRI show the ideal coil position. FLASH, fast low angle shot; PC, phase contrast; RF, radio frequency.

    (TIFF)

    S2 Fig. Phase images from the different representative rats with different TEs and flip angles.

    (A) Phase images from a representative rat with different TEs, i.e., 2.75, 3.0, and 3.2 ms. The right panel shows the mean blood flow velocity (mean ± SEM) from left images with NArteriole = 48 and NVenule = 22. (B) Phase images from a representative rat with different flip angles, i.e., 25°, 30°, and 35°. The right panel shows the mean CBFv from left images with NArteriole = 38 and NVenule = 14. The data underlying this figure can be found in S4 Data. CBFv, cerebral blood flow–related velocity; TE, echo time.

    (TIFF)

    S3 Fig. The bSSFP-based single-vessel BOLD/CBV-fMRI and the PC-based single-vessel CBFv measurement from a representative rat.

    (A) The evoked bSSFP-based BOLD- (left) and CBV- (right) fMRI maps overlaid on the A–V map of a representative rat, with the voxel-wise time courses from the ROIs of individual venule and arteriole voxels (10 seconds on and 35 seconds off for 10 epochs plotted in a 3 × 3 matrix). (B) The evoked CBFv functional maps overlaid on the A–V map of a representative rat. The voxel-wise time courses of CBFv changes from the same ROIs of individual venule and arteriole voxels (10 seconds on and 50 seconds off for 12 epochs plotted in a 3 x 3 matrix). A–V, arteriole–venule; BOLD, blood oxygenation level–dependent; bSSFP, balanced steady-state free precession; CBFv, cerebral blood flow–related velocity; CBV, cerebral blood volume; PC, phase contrast; ROI, region of interest.

    (TIFF)

    S4 Fig. The PC-based single-vessel resting-state CBFv-fMRI mapping.

    (A) The A–V map shows bright dot as arterioles and dark dots as venules from one representative rat. Seed-based correlation maps were overlapped on the A–V map, showing 2 venule seeds (V1 and V2) and 2 arteriole seeds (A1 and A2). The venule-based correlation map shows positive correlations to other venules, but negative correlations with arterioles. In contrast, the arteriole-based correlation map shows positive correlations to other arterioles, but negative correlations with venules. (B) The enlarged CBFv map shows the venule with positive velocity (bright dots) and arterioles with negative velocity (dark dots). The venule seed-based CBFv correlation map was overlapped on the CBFv map, showing the positive correlation on surrounding venule voxels (bright dots), and negative correlation on surrounding arteriole voxels (dark dots). (C) The normalized time course extracted from venule and arteriole voxels, showing correlated low-frequency signal fluctuation. (D) The PSD plot of resting state CBFv dynamics from arteriole and venule voxels shows the slightly higher power from 0.01 to 0.04Hz (n = 5). The data underlying this figure can be found in S5 Data. A–V, arteriole–venule; CBFv, cerebral blood flow–related velocity; PC, phase contrast; PSD, power spectrum density.

    (TIFF)

    S5 Fig. The PC-based CBFv mapping in rats with the 9.4 T scanner.

    (A) The vectorized flow velocity (CBFv) map with 67 × 67 um2 in-plane resolution shows venules (bright dots) with positive CBFv values and arterioles (dark dots) with negative CBFv values. (B) The bar graph shows the averaged velocity for arterioles (−1.37 ± 0.94 mm/s) and venules (1.02 ± 0.32 mm/s) from 4 rats. The data underlying this figure can be found in S6 Data. CBFv, cerebral blood flow–related velocity; PC, phase contrast.

    (TIFF)

    S1 Movie. The bSSFP-based single-vessel BOLD/CBV-fMRI and the PC-MRI based single-vessel CBFv-fMRI in the rat cortex.

    The left panel shows the evoked bSSFP-based BOLD- (upper) and CBV- (lower) fMRI responses with a representative trace from single venule and arteriole voxels (arrow) (10 seconds on and 35 seconds off for a total of 45-second time window with TR = 1 second). The right panel shows the evoked PC-based CBFv-fMRI responses with a representative trace from single venule (upper) and arteriole (lower) voxels (10 seconds on and 50 seconds off for a total of 60-second time window with TR = 4 seconds). Note that the underlay is the A–V map showing venules as dark voxels and arterioles as bright voxels. A–V, arteriole–venule; BOLD, blood oxygenation level–dependent; bSSFP, balanced steady-state free precession; CBFv, cerebral blood flow–related velocity; CBV, cerebral blood volume; PC, phase contrast.

    (MP4)

    S1 Data. The flow velocity estimates from the 5 ROIs with different TEs and different pump rates.

    The flow velocity estimates from the 5 ROIs with different TEs (4.2, 4.5, 5.0, and 6.0 ms) and different pump rates (0, 2.3, 4.5, 6.8, and 9 mm/s). The linear fitting is calculated from averaged velocity of venules and arterioles.ROI, region of interest; TE, echo time.

    (XLSX)

    S2 Data. Scatter plot of the flow velocities from individual arterioles and venules as the function of the normalized signal intensities of each vessel in the A–V map from 11 rats.

    Fig 2D upper panel: The flow velocities from individual arterioles and venules as the function of the normalized signal intensities of each vessel in the A–V map. The raw data was acquired from 11 animals. Fig 2D lower panel: Mean velocity of arterioles and venules for the bar graph from 11 animals. MATLAB code and mat file: The MATLAB code and raw data for the histogram of the blood velocity distribution across arterioles and venules from the animals. A–V, arteriole–venule.

    (RAR)

    S3 Data. Hemodynamic signal data for single-vessel BOLD, CBV, and CBFv-fMRI measurement.

    Fig 3B: The time courses of evoked bSSFP-BOLD and CBV-fMRI with the block design stimulation paradigm from venules and arterioles. Fig 3C: The averaged time courses of the fractional change for evoked BOLD and CBV signals from venule and arteriole ROIs and the raw data from 3 animals. Fig 3D: The time courses of the evoked CBFv changes from the arteriole and venule ROIs from both arterioles and venules with the block design stimulation paradigm. Fig 3E: The averaged time courses of the evoked CBFv changes from arteriole and venule ROIs with the block design stimulation paradigm and the raw data from 5 animals. Fig 3F: The venules and arterioles ROIs peak signals for BOLD, CBV, and CBFv measurements from different animals. BOLD, blood oxygenation level–dependent; bSSFP, balanced steady-state free precession; CBFv, cerebral blood flow–related velocity; CBV, cerebral blood volume; ROI, region of interest.

    (XLSX)

    S4 Data. Blood flow velocity with different TEs and flip angles.

    S2A Fig: The blood flow velocity of 48 arterioles and 22 venules with different TEs (2.75, 3.0, and 3.2 ms). S2B Fig: The blood flow velocity of 38 arterioles and 14 venules with different flip angles (25°, 30°, 35°). TE, echo time.

    (XLSX)

    S5 Data. The PC-based single-vessel resting-state CBFv-fMRI PSD.

    The PSD of resting state CBFv dynamics from arteriole and venule voxels from 5 animals. CBFv, cerebral blood flow–related velocity; PC, phase contrast; PSD, power spectrum density.

    (XLSX)

    S6 Data. The PC-based CBFv mapping in rats with the 9.4 T scanner.

    The averaged velocity for arterioles and venules from 4 animals. CBFv, cerebral blood flow–related velocity; PC, phase contrast.

    (XLSX)

    Attachment

    Submitted filename: Response to reviewer_comments.docx

    Attachment

    Submitted filename: Responses to reviewer comments_0720.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLoS Biology are provided here courtesy of PLOS

    RESOURCES